$WRB

WR Berkley earnings beat by $0.02, revenue fell short of estimates

WR Berkley (WRB) reported Q3 EPS of $1.17, beating estimates by $0.02, but revenue of $3.74B missed expectations of $3.82B. The stock closed at $74.11, up 0.93% over 3 months. WR Berkley's Financial Health score is rated 'great performance' by InvestingPro. The company saw 13 positive EPS revisions in the last 90 days.

Original reporting
Published Oct 19, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WRB
Bullish
high confidence
Mentioned
$WRB
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$WRBBullishMed
01

Why it matters

The EPS beat may trigger short-term buying, but revenue miss could limit upside; traders should monitor guidance for next moves.

02

Market read

Earnings release provides fresh data that can influence WR Berkley's stock and the broader insurance sector.

03

What to watch

Potential impact of upcoming guidance or macro insurance trends not covered in the brief.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

WR Berkley is a mid-cap specialty insurer; its earnings are closely watched by financial sector investors.

Company-level read

Ticker impact

$WRBBullishHigh confidence
Context

WR Berkley reported Q3 EPS of $1.17, beating estimates by $0.02, while revenue missed at $3.74B versus $3.82B consensus.

Expected impact

likely modest upside as investors price in the EPS beat

Evidence & confidence

EPS beat is a fresh, material data point; revenue miss tempers enthusiasm, so impact is limited but positive.

Market effects

Insurance sector may see slight uplift as peers' earnings are compared to WR Berkley's beat.

U.S. market may experience a small positive bias in financials during post-market trading.

Limited; the news is primarily relevant to U.S. investors and insurers.

Counterpoint

Revenue miss could signal underlying demand weakness, suggesting caution despite EPS beat.

Key entities

  • WR Berkley

    Specialty insurer reporting Q3 results.

Related articles

$WRBMedAI 8/10

W.R. Berkley stock dips as Q3 net premiums written, ROE miss estimates

W. R. Berkley's Q3 net premiums written and ROE missed estimates, despite operating income per share beating expectations. Shares fell 4.28% to $70.94 in post-market trading. Total revenue decreased to $3.74B from $3.77B a year ago, below the $3.83B consensus. Net investment income grew to $383.54M from $351.24M, but fell short of the $413.85M estimate.

$WRBHighAI 8/10

W.R. Berkley stock slips over 3% on Q3 top-line miss

W.R. Berkley Corp (WRB) reported Q3 adjusted EPS of $1.17, beating estimates, but revenue of $3.74B missed expectations. Shares fell 3.4% in after-hours trading. Revenue grew 1.8% YoY, while net income declined. The company reported strong returns on equity and improved underwriting income.

$WRBHigh

W.R. Berkley: Q3 Earnings Snapshot

W.R. Berkley (WRB) reported Q3 net income of $446M, or $1.14 per share, beating analyst estimates. Adjusted EPS was $1.17. Revenue was $3.74B, missing expectations of $3.8B. The company's results were compared to Zacks Investment Research's analyst forecasts.